Genes Tech Group Holdings Company Limited (stock code: 08257) released its monthly return for equity issuer for the period ended 31 January 2026. The authorized, registered share capital stands at 2,000,000,000 ordinary shares at a par value of HKD0.01 each, totaling HKD20,000,000. The total issued share capital remains at 1,000,000,000 ordinary shares, with no treasury shares reported.

The company confirms that minimum public float requirements have been met. Details also indicate a share option scheme adopted on 20 June 2017, with 100,000,000 potential shares that can be issued. No new shares were issued and no share options were exercised during the January 2026 reporting period.

According to information provided, the filing was submitted by the Company Secretary, confirming compliance with all necessary listing rules and regulations.